Newbury Pharmaceuticals AB Logo

Newbury Pharmaceuticals AB

NEWBRY | ST

Overview

Corporate Details

ISIN(s):
SE0015244884
LEI:
549300F7XHU3I8CWL373
Country:
Sweden
Address:
Medicon Village, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company founded in 2020. It focuses on building and marketing a portfolio of proprietary and licensed specialty prescription drugs and branded products. The company operates primarily in the Scandinavian market, positioning itself as a local alternative to multinational corporations. Its product pipeline is concentrated on providing treatment solutions within key therapeutic areas, including oncology, rare diseases, and neurology.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Newbury Pharmaceuticals AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2018-10-05 13:14
Regulatory News Service
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
English 10.7 KB
2017-06-29 13:30
Report Publication Announcement
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
English 11.1 KB

Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-29 Johan Strömqvist Other Sell 13,564 40,692.00 SEK
2025-04-29 Johan Strömqvist Other Sell 10,400 30,888.00 SEK
2025-04-29 Johan Strömqvist Other Buy 10,200 30,804.00 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,570.50 SEK
2025-04-29 Johan Strömqvist Other Buy 5,000 15,200.00 SEK
2025-04-29 Johan Strömqvist Other Sell 2,436 7,332.36 SEK
2025-04-29 Johan Strömqvist Other Sell 100 305.00 SEK
2024-08-03 Andreas Hedskog Other Buy 200,000 178,000.00 SEK
2024-08-03 Andreas Hedskog Other Other 200,000 N/A
2024-01-22 Alsakali Equity AB Other Buy 4,000 18,920.00 SEK

Peer Companies

Company Country Ticker View
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo Japan 4582
Synbiotic SE Logo
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany SBX
Synektik S.A. Logo
Radiopharmaceuticals, medical devices & IT solutions for oncology, cardiology, and neurology.
Poland SNT
Synthaverse S.A. Logo
Develops and sells oncology, hematology, and immunology drugs and vaccines globally.
Poland BML
TAIKO PHARMACEUTICAL CO., LTD. Logo Japan 4574
Takeda Pharmaceutical Company Limited Logo Japan 4502
TAUNS Laboratories, Inc. Logo Japan 197A
Tchaikapharma High Quality Medicines AD Logo
Manufactures affordable generic & complex polypill medicines for socially significant diseases.
Bulgaria THQM
Teva Pharmaceutical Industries Ltd. Logo
A global leader in generic drugs and innovative medicines for CNS and immuno-oncology.
Israel TEVA